1. Use of Autoantibodies to Detect the Onset of Breast Cancer
    Jérôme Lacombe et al, 2014, Journal of Immunology Research CrossRef
  2. Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
    Rick L. Evans et al, 2018, BMC Cancer CrossRef
  3. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis
    Jian-Xiang Shi et al, 2015, Expert Review of Molecular Diagnostics CrossRef
  4. Autoantibodies as Potential Biomarkers in Breast Cancer
    Jingyi Qiu et al, 2018, Biosensors CrossRef
  5. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer
    Peng Wang et al, 2018, J Cell Biochem CrossRef
  6. Fast and Fully-Automated Detection and Segmentation of Pulmonary Nodules in Thoracic CT Scans Using Deep Convolutional Neural Networks
    Xia Huang et al, 2019, Computerized Medical Imaging and Graphics CrossRef
  7. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.
    Cong Zhang et al, 2014, Tumour Biol. CrossRef
  8. Study of circulating antibodies against CD25 and FOXP3 in breast cancer
    Tong Liu et al, 2014, Tumor Biol. CrossRef
  9. Evaluation of Diagnostic Value in Using a Panel of Multiple Tumor-Associated Antigens for Immunodiagnosis of Cancer
    Peng Wang et al, 2014, Journal of Immunology Research CrossRef
  10. Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens
    Liping Dai et al, 2014, Journal of Immunology Research CrossRef
  11. null
    Félix Fernández-Madrid et al, 2014 CrossRef
  12. Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer
    Yonglong Jin et al, 2015, Asia-Pac J Clin Oncol CrossRef
  13. Mini-Array of Multiple Tumor-associated Antigens (TAAs) in the Immunodiagnosis of Esophageal Cancer
    Jie-Jie Qin et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  14. Investigation of circulating antibodies to ANXA1 in breast cancer.
    Yile Huang et al, 2015, Tumour Biol. CrossRef
  15. Circulating antibodies to p16 protein-derived peptides in breast cancer
    CAIREN CHEN et al, 2015 CrossRef
  16. Tumour-Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta-Analysis
    J. Xia et al, 2016, Scand J Immunol CrossRef
  17. Interaction of Serum Antibodies from Breast Cancer Patients with Synthetic Peptides
    S. V. Podlesnykh et al, 2016, Bull Exp Biol Med CrossRef
  18. Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection
    Olga Kostianets et al, 2017, Biomarkers CrossRef
  19. Establishment and validation of an immunodiagnostic model for prediction of breast cancer
    Cuipeng Qiu et al, 2019, OncoImmunology CrossRef
  20. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort
    Henry A. Adeola et al, 2016, Oncotarget CrossRef
  21. Serum Analysis of Women with Early-Stage Breast Cancer Using a Mini-Array of Tumor-Associated Antigens
    Alma Rosa Oaxaca-Camacho et al, 2020, Biosensors CrossRef
  22. Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients
    Guoyu Mu et al, 2020, Breast Cancer CrossRef
  23. Classifying Patients for Breast Cancer by Detection of Autoantibodies against a Panel of Conformation-Carrying Antigens
    Rick L. Evans et al, 2014, Cancer Prev Res CrossRef
  24. A Multiparametric Serum Marker Panel as a Complementary Test to Mammography for the Diagnosis of Node-Negative Early-Stage Breast Cancer and DCIS in Young Women
    Jérôme Lacombe et al, 2014, Cancer Epidemiol Biomarkers Prev CrossRef
  25. Autoantibodies in Early Detection of Breast Cancer
    Femina Rauf et al, 2020, Cancer Epidemiol Biomarkers Prev CrossRef
  26. The implication of autoantibodies in early diagnosis and monitoring of plasmonic photothermal therapy in the treatment of feline mammary carcinoma
    Asmaa M. El-Rasikh et al, 2021, Sci Rep CrossRef
  27. Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC).
    Liping Dai et al, 2013, Exp Hematol Oncol CrossRef
  28. The Autoantibodies against Tumor-Associated Antigens as Potential Blood-Based Biomarkers in Thyroid Neoplasia: Rationales, Opportunities and Challenges
    Pavel V. Belousov, 2022, Biomedicines CrossRef
  29. null
    Prachi Gupta, 2022 CrossRef
  30. Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis
    Thejas Kathrikolly et al, 2022, Syst Rev CrossRef
  31. Autoantibodies as biomarkers for breast cancer diagnosis and prognosis
    Ruozhu Yang et al, 2022, Front. Immunol. CrossRef
  32. null
    Pauline Zaenker et al, 2023 CrossRef
  33. A Luminex Approach to Develop an Anti-Tumor-Associated Antigen Autoantibody Panel for the Detection of Prostate Cancer in Racially/Ethnically Diverse Populations
    Cuipeng Qiu et al, 2023, Cancers CrossRef
  34. null
    Rajasekaran Subbarayan et al, 2024 CrossRef